Compound 694
Identifiers
- Canonical SMILES:
OCC(CO)NCc1ccc(cc1)C(=O)NCc1cccc(CN(Cc2ccc(cc2)-c2ccccc2)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)c1
- InChi:
InChI=1S/C38H37Cl2N3O6S/c39-33-18-35(40)37(46)36(19-33)50(48,49)43(22-27-11-13-31(14-12-27)30-7-2-1-3-8-30)23-29-6-4-5-28(17-29)21-42-38(47)32-15-9-26(10-16-32)20-41-34(24-44)25-45/h1-19,34,41,44-46H,20-25H2,(H,42,47)
- InChiKey:
SGIGHAHEKUKVMI-UHFFFAOYSA-N
External links
66616554 |
External search
Bibliography (1)
Publication | Name |
---|---|
Kyoung S. Kim, Robert M. Borzilleri, Zhen-Wei Cai, Kap-Sun Yeung, Bristol-Myers Squibb Company. . Hydroxyphenylsulfonamides as antiapoptotic bcl inhibitors None. | 39 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 6.82 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 733.18 g/mol | |||
HBA | 9 | |||
HBD | 5 | |||
HBA + HBD | 14 | |||
AlogP | 5.11 | |||
TPSA | 139.20 | |||
RB | 14 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2009152082 | 39 | BCL2 P10415 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 6.82 | |
WO2009152082 | 39 | MCL1 Q07820 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 6.68 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5528 | N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide | DB07115 | |
0.5312 | 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid | DB03124 | |
0.5217 | 2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE | DB08000 | |
0.5000 | Sulfabenzamide | DB09355 | |
0.4961 | Saccharin | DB12418 | |
0.4722 | {4-[(CARBOXYMETHOXY)CARBONYL]-3,3-DIOXIDO-1-OXONAPHTHO[1,2-D]ISOTHIAZOL-2(1H)-YL}ACETIC ACID | DB07999 | |
0.4663 | Sivelestat | DB12863 | |
0.4629 | 2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid | DB03207 | |
0.4521 | Repinotan | DB06506 | |
0.4512 | Sp-722 | DB04503 | |
0.4512 | Evatanepag | DB12022 | |
0.4412 | Aminodi(Ethyloxy)Ethylaminocarbonylbenzenesulfonamide | DB02535 | |
0.4355 | N-Benzyl-4-Sulfamoyl-Benzamide | DB01748 | |
0.4278 | N-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE | DB04588 | |
0.4222 | 3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE | DB08487 |